|
Real-time Estimate
Cboe BZX
20:58:32 09/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 21.64 USD | -1.99% |
|
-4.70% | +31.89% |
| 09-04 | Denali Therapeutics Insider Sold Shares Worth $261,929, According to a Recent SEC Filing | MT |
| 08-25 | B. Riley Adjusts Denali Therapeutics Price Target to $35 From $30, Maintains Buy Rating | MT |
| Market Cap | 3.53B 3.04B 2.86B 2.61B 4.88B 336B 4.89B 33.89B 13.1B 171B 13.25B 12.97B 542B | P/E 2026 * |
-9.54x | P/E 2027 * | -9.58x |
|---|---|---|---|---|---|
| Enterprise Value | 2.82B 2.43B 2.29B 2.08B 3.9B 268B 3.91B 27.09B 10.47B 137B 10.59B 10.36B 433B | EV / Sales 2026 * |
56.1x | EV / Sales 2027 * | 21.9x |
| Free-Float |
90.04% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DNLI | Delayed | |
CBOE
| DNLI | Real-time | |
|
Boerse Muenchen
| 4DN | Real-time | |
|
Deutsche Boerse AG
| 4DN | Delayed | |
|
Tradegate
| 4DN | Real-time | |
|
Börse Stuttgart
| 4DN | Delayed |
Last Transcript : Denali Therapeutics Inc.
| 1 day | -1.99% | ||
| 1 week | -4.70% | ||
| Current month | -8.35% | ||
| 1 month | -12.90% | ||
| 3 months | +4.74% | ||
| 6 months | +2.18% | ||
| Current year | +31.89% |
| 1 week | 21.34 |  | 23.02 |
| 1 month | 21.34 | | 25.7 |
| Current year | 15.34 | | 27.3 |
| 1 year | 12.58 | | 27.3 |
| 3 years | 10.57 | | 33.33 |
| 5 years | 10.57 | | 56.08 |
| 10 years | 10.57 | | 93.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Schuth
DFI | Director of Finance/CFO | 52 | 30/04/2022 |
Ryan Watts
CEO | Chief Executive Officer | 50 | 31/07/2015 |
Peter Chin
CTO | Chief Tech/Sci/R&D Officer | 58 | 05/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ryan Watts
BRD | Director/Board Member | 50 | 28/02/2015 |
Jay Flatley
BRD | Director/Board Member | 73 | 31/03/2015 |
David Schenkein
BRD | Director/Board Member | 68 | 31/03/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/09/26 | Sell | Director | -11,439 | 0.0072% | ||
| 01/09/26 | Sell | Founder | -2,768 | 0.0017% | ||
| 12/08/26 | Don | Founder | -32,220 | 0.0203% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.99% | -4.70% | +41.76% | -9.01% | 3.53B | |
| -0.94% | +0.31% | +40.04% | +103.25% | 69.19B | |
| -0.07% | -3.93% | +32.54% | +75.96% | 62.97B | |
| +3.39% | +2.16% | -12.12% | +388.15% | 27.27B | |
| -0.47% | -5.53% | -3.94% | -16.85% | 24.78B | |
| -0.93% | -1.29% | +25.30% | +16.70% | 25.8B | |
| -1.43% | -1.89% | +21.32% | -17.67% | 20.11B | |
| -4.27% | +2.67% | +219.02% | +362.48% | 18.47B | |
| -1.43% | -1.80% | -8.64% | +537.09% | 14.88B | |
| +1.08% | -1.00% | +51.38% | +163.52% | 14.29B | |
| Average | -0.74% | -0.78% | +40.66% | +160.36% | 28.13B | |
| Weighted average by Cap. | -0.50% | -0.82% | +36.51% | +139.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.26M 43.24M 40.72M 37.1M 69.42M 4.78B 69.69M 483M 187M 2.44B 189M 185M 7.72B | 127M 109M 103M 93.67M 175M 12.07B 176M 1.22B 471M 6.15B 476M 466M 19.49B |
| Net income | -454M -391M -368M -336M -628M -43.24B -630M -4.36B -1.69B -22.03B -1.71B -1.67B -69.8B | -453M -389M -367M -334M -625M -43.06B -628M -4.35B -1.68B -21.94B -1.7B -1.66B -69.5B |
| Net Debt | -708M -610M -574M -523M -979M -67.41B -982M -6.8B -2.63B -34.34B -2.66B -2.6B -109B | -749M -644M -607M -553M -1.03B -71.24B -1.04B -7.19B -2.78B -36.29B -2.81B -2.75B -115B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/09/26 | US$21.78 | -1.36% | 1,381,973 |
| 08/09/26 | US$22.08 | -0.90% | 1,653,769 |
| 04/09/26 | US$22.28 | -2.28% | 799,633 |
| 03/09/26 | US$22.80 | -0.22% | 1,727,981 |
| 02/09/26 | US$22.85 | -1.78% | 1,768,603 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DNLI Stock
Select your edition
All financial news and data tailored to specific country editions
